Abstract:Tea polyphenols play roles in the augmentation of antitumor effects, the reversal of multidrug resistance, and the reduction of side effects of antitumor drugs. Tea polyphenols could be used as biochemical modulators in cancer therapy. In this study, the interaction of daunorubicin (DNR) with human serum albumin ( HSA) and the effect of epigallocatechin gallate (EGCG) on the binding process under physiological condition were studied by fluorescence spectroscopy, UV-Vis absorption spectroscopy, circular dichroism (CD) spectroscopy, and dynamic light scattering (DLS). The cytotoxicity of DNR single drug, EGCG+DNR combined drug, and their complexes with HSA against human cervical cancer HeLa cell line was determined by MTT assay. Fluorescence quenching result and difference spectra of UV-Vis absorption revealed the formation of a static complex between DNR and HSA. Quenching constants, binding constants, the numbers of binding sites, enthalpy and entropy changes were obtained from fluorescence data. Positive enthalpy and entropy changes indicated that the binding of DNR to HSA was mainly driven by entropy. The hydrophobic interaction was the main driving force. Site marker competitive experiments combined with synchronous fluorescence spectra showed that DNR mainly bound to subdomain IIA of HSA and was closer to tryptophan residues. In HSA+EGCG+DNR ternary system, the fluorescence data processing model of the ternary system was established. The number of binding sites and binding constants for DNR-HSA interaction in the presence of EGCG obtained by Matlab fitting were obviously decreased in the presence of EGCG. This indicated that the presence of EGCG might decrease the binding affinities of DNR to HSA. In addition, in the presence of EGCG, the binding constant of DNR to HSA increased with the elevation of temperature. This implied that the main driving force for the binding process was still the hydrophobic interactions. CD spectroscopy and DLS studies showed that drug-protein binding could affect the conformation and particle size of the protein, resulting in a decrease in the a-helical content of HSA and an increase in particle size. The a-helical content in (FISA+ EGCG)+DNR ternary system was greater than that in the corresponding FISA+DNR binary system, while the hydraulic diameter of the ternary system was smaller than that of the binary system. This indicated the presence of EGCG weakened the binding of DNR to HSA due to the competitive binding between EGCG and DNR. This conclusion was consistent with the fluorescence experiment result of the ternary system. Furthermore, the cytotoxicity of DNR and HSA+DNR complex in the presence or absence of EGCG was discussed, and the results indicated that the combination of DNR with EGCG had the synergistic effect and HSA can enhance the cytotoxicity of DNR. Obtained results would provide beneficial information on the combination of EGCG and DNR in the clinic. This study showed that the spectroscopic method could provide strong support for the study of the interaction between combined drugs and proteins.

Specific interaction of 4'-O-(a-l-Cladinosyl) daunorubicin with human serum albumin: The binding site II on HSA molecular using spectroscopy and modeling.

Study of the Interaction of Aglycon of Daunorubicin with Human Serum Albumin by Spectroscopy and Modeling

Interaction of anthracycline disaccharide with human serum albumin: investigation by fluorescence spectroscopic technique and modeling studies.

The effect of simultaneous binding of doxorubicin and cyclophosphamide on the human serum albumin structure

Study on the Interaction of Adriamycin Rare Earth Complexes with Human Serum Albumin

The Study on the Interaction Between Human Serum Albumin and a New Reagent with Antitumour Activity by Spectrophotometric Methods

Spectroscopic Investigation on the Binding of Antineoplastic Drug Oxaliplatin to Human Serum Albumin and Molecular Modeling

Probing the Binding Reaction of Cytarabine to Human Serum Albumin Using Multispectroscopic Techniques with the Aid of Molecular Docking

Analysis on the interaction and binding properties of daphnoretin and human serum albumin in the presence of cisplatin: multi-spectroscopic methods and docking simulation

Investigations on the Interactions Between Naphthalimide-Based Anti-Tumor Drugs and Human Serum Albumin by Spectroscopic and Molecular Modeling Methods

Unveiling the molecular mechanism of pH-dependent interactions of human serum albumin with chemotherapeutic agent doxorubicin: A combined spectroscopic and constant-pH molecular dynamics study

Study on the interaction between human serum albumin and a novel bioactive acridine derivative using optical spectroscopy.

Interaction of the docetaxel with human serum albumin using optical spectroscopy methods

Thermodynamic Study on Interaction Between Anti-Tumor Drug 5-Fluorouracil and Human Serum Albumin

Probing the Anticancer-Drug-binding-induced Microenvironment Alterations in Subdomain IIA of Human Serum Albumin.

Molecular Interaction Study of Flavonoid Derivative 3d with Human Serum Albumin Using Multispectroscopic and Molecular Modeling Approach

Spectroscopic and Cytotoxicity Study on the Influence of (-)-Epigallocatechin-3-Gallate on the Interaction of Daunorubicin with Human Serum Albumin

Studies on the Binding of A Carditionic Agent to Human Serum Albumin by Two-Dimensional Correlation Fluorescence Spectroscopy and Molecular Modeling

Combined spectroscopy and cyclic voltammetry investigates the interaction between [(η6-p-cymene)Ru(benzaldehyde-N(4)-phenylthiosemicarbazone)Cl]Cl anticancer drug and human serum albumin

Uncovering the Molecular and Physiological Processes of Anticancer Leads Binding Human Serum Albumin: A Physical Insight into Drug Efficacy

The interaction of bovine serum albumin with doxorubicin-loaded superparamagnetic iron oxide nanoparticles: spectroscope and molecular modelling identification.